QTTB SCHEDULE 13G/A: SEC filing
Opaleye Management Inc., Opaleye, L.P., and James Silverman
Filed with the SEC on · accession 0001493152-26-050448
QTTB filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +4.5% by the first close after the filing.
Summary of the filing
Opaleye Management Inc., Opaleye, L.P., and James Silverman filed a joint filing agreement as an amendment to their Schedule 13G regarding their beneficial ownership of Q32 Bio Inc. common stock.
Key details
How QTTB stock reacted
Close before
$8.85
Nov 5, 2026
First close after
+4.52%
$9.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for QTTB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for QTTB?
Click hereFrequently asked questions
What did QTTB file with the SEC on Nov 6, 2026?
QTTB filed a SCHEDULE 13G/A (SEC filing). Opaleye Management Inc., Opaleye, L.P., and James Silverman filed a joint filing agreement as an amendment to their Schedule 13G regarding their beneficial ownership of Q32 Bio Inc. common stock.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did QTTB stock react to this filing?
QTTB closed at $8.85 before the filing and $9.25 on Nov 6, 2026 (+4.52%).
Other QTTB SEC filings
- SCHEDULE 13G/A · SEC filingNov 6, 2026
- 8-K · SEC filingNov 4, 2026
- 10-Q · SEC filingNov 4, 2026
- SCHEDULE 13G · SEC filingOct 28, 2026
- SCHEDULE 13G · SEC filingOct 9, 2026
- 8-K · Fda approvalSep 30, 2026
- 8-K · Executive departureSep 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 8-K · SEC filingAug 5, 2026
Get alerts when QTTB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days